Literature DB >> 28903017

Is a high tibial osteotomy (HTO) superior to non-surgical treatment in patients with varus malaligned medial knee osteoarthritis (OA)? A propensity matched study using 2 randomized controlled trial (RCT) datasets.

M V van Outeren1, J H Waarsing2, R W Brouwer3, J A N Verhaar2, M Reijman2, S M A Bierma-Zeinstra4.   

Abstract

OBJECTIVE: No randomized controlled trial (RCT) has compared the high tibial osteotomy (HTO) with non-surgical treatment in patients with medial knee osteoarthritis (OA) and varus malalignment. The aim was to compare the effectiveness of an unloader brace treatment or a usual care program to the HTO regarding pain severity and knee function.
DESIGN: Surgical treatment (HTO) to two non-surgical options was compared by combining the data of two RCTs. One RCT (n = 117) compared an unloader brace to usual care treatment; the other RCT (n = 92) compared closing to opening wedge HTO. One-to-many propensity score matching was used to equalize patient characteristics. We compared clinical outcome at 1 year follow-up (VAS pain (0-10) and knee function (HSS, 0-100)) with mixed model analysis.
RESULTS: Propensity score matching resulted in a comparison of 30 brace patient with 83 HTO patients, and of 28 usual care patients with 71 HTO patients. Pain at 1 year after HTO (VAS 3.8) was lower than after valgus bracing (VAS 5.0) with a mean difference of -1.1 (95% CI -2.2; -0.1). Function showed a nonsignificant mean difference of 2.1 [95% CI -3.1; 7.3]. Comparing HTO to usual care a difference was seen in pain (-1.7 [95% CI -2.8; -0.6]) and function (6.6 [95% CI 0.2; 13.1]), in favor of the HTO.
CONCLUSIONS: Our data suggest that HTO was more effective in pain reduction compared to both non-surgical treatments. Function improved only when HTO was compared to usual care treatment. These small differences question the benefits of surgical treatment over the brace treatment.
Copyright © 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bracing; HTO; OA; Propensity score matching

Mesh:

Substances:

Year:  2017        PMID: 28903017     DOI: 10.1016/j.joca.2017.09.003

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  6 in total

Review 1.  Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading.

Authors:  Lianzhi Chen; Jessica Jun Yi Zheng; Guangyi Li; Jun Yuan; Jay R Ebert; Hengyuan Li; John Papadimitriou; Qingwen Wang; David Wood; Christopher W Jones; Minghao Zheng
Journal:  J Orthop Translat       Date:  2020-05-15       Impact factor: 5.191

Review 2.  Medial compartment osteoarthritis of the knee: a review of surgical options.

Authors:  Daniel J McCormack; Darren Puttock; Steven P Godsiff
Journal:  EFORT Open Rev       Date:  2021-02-01

Review 3.  Instructive cartilage regeneration modalities with advanced therapeutic implantations under abnormal conditions.

Authors:  Zhonghan Wang; Hanxiang Le; Yanbing Wang; He Liu; Zuhao Li; Xiaoyu Yang; Chenyu Wang; Jianxun Ding; Xuesi Chen
Journal:  Bioact Mater       Date:  2021-11-18

4.  Large medial meniscus extrusion and varus are poor prognostic factors of arthroscopic partial meniscectomy for degenerative medial meniscus lesions.

Authors:  Tao Xu; Liuhai Xu; Xinzhi Li; You Zhou
Journal:  J Orthop Surg Res       Date:  2022-03-18       Impact factor: 2.359

Review 5.  Therapeutic potential of nanotechnology-based approaches in osteoarthritis.

Authors:  Likang Xiao; Jiarui Cui; Zhuang Sun; Yunke Liu; Jia Zheng; Yonghui Dong
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

6.  The molecular profile of synovial fluid changes upon joint distraction and is associated with clinical response in knee osteoarthritis.

Authors:  F E Watt; B Hamid; C Garriga; A Judge; R Hrusecka; R J H Custers; M P Jansen; F P Lafeber; S C Mastbergen; T L Vincent
Journal:  Osteoarthritis Cartilage       Date:  2020-01-02       Impact factor: 6.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.